Literature DB >> 17967416

Characterizations of a loss-of-function mutation in the Kir3.4 channel subunit.

Kirstine Calloe1, Lasse Steen Ravn, Nicole Schmitt, Jin Liang Sui, Morten Duno, Stig Haunso, Morten Grunnet, Jesper Hastrup Svendsen, Soren-Peter Olesen.   

Abstract

Kir3.4 and Kir3.1 potassium channel subunits mediate the acetylcholine induced inwardly rectifying current I(KACh) in the heart. We found a glycine to arginine substitution in codon 247 of Kir3.4 in a patient with a single episode of atrial fibrillation (AF). Expression in Xenopus laevis oocytes and two-electrode voltage-clamp revealed that Kir3.4-G247R basal current was reduced compared to wild-type Kir3.4 and co-expression with the muscarinic acetylcholine receptor type 2 showed that also the acetylcholine induced current was severely reduced in Kir3.4-G247R, indicating that the mutation interfered with activation by the stimulatory G betagamma-subunits. Co-expression of Kir3.4-G247R with wild-type Kir3.4 or Kir3.1 had a compensating effect on both basal current levels and the response to muscarinic stimulation suggesting the function of Kir3.4-G247R is compensated in vivo. This may explain the lack of clear clinical manifestations and further studies are necessary to elucidate if mutations in Kir3.4 are predisposing AF.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17967416     DOI: 10.1016/j.bbrc.2007.10.106

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Ion channel mutations in AF: signal or noise?

Authors:  Patrick T Ellinor; Calum A MacRae
Journal:  Heart Rhythm       Date:  2008-01-17       Impact factor: 6.343

Review 2.  Genetics of atrial fibrillation: from families to genomes.

Authors:  Ingrid E Christophersen; Patrick T Ellinor
Journal:  J Hum Genet       Date:  2015-05-21       Impact factor: 3.172

3.  KCNJ5 mutations in the National Institutes of Health cohort of patients with primary hyperaldosteronism: an infrequent genetic cause of Conn's syndrome.

Authors:  Paraskevi Xekouki; Michael M Hatch; Lin Lin; De Alexandre Rodrigo; Monalisa Azevedo; Maria de la Luz Sierra; Isaac Levy; Emmanouil Saloustros; Andreas Moraitis; Anelia Horvath; E Kebebew; Dax A Hoffman; Constantine A Stratakis
Journal:  Endocr Relat Cancer       Date:  2012-05-03       Impact factor: 5.678

4.  Decreased gene expression of KACh and KATP channels in hyperthyroid rabbit atria.

Authors:  Feng Zhang; Guang Hai Zhou; Qi An; Jie Yang; Yu Hao Wang; Jia Quan Zhu; Song Nan Jin; Jin Fu Wen
Journal:  Int J Clin Exp Pathol       Date:  2022-03-15

5.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

6.  Polymorphisms but not mutations of the KCNQ1 gene are associated with lone atrial fibrillation in the Chinese Han population.

Authors:  Hui-min Chu; Ming-jun Feng; Yi-gang Li; Yi-xin Zhang; Ji-fang Ma; Bin He; Yi-bo Yu; Jing Liu; Xiao-min Chen
Journal:  ScientificWorldJournal       Date:  2013-04-18

Review 7.  Neuronal and Cardiovascular Potassium Channels as Therapeutic Drug Targets: Promise and Pitfalls.

Authors:  Edward S A Humphries; Caroline Dart
Journal:  J Biomol Screen       Date:  2015-08-24

Review 8.  Genetics of Atrial Fibrillation.

Authors:  Julien Feghaly; Patrick Zakka; Barry London; Calum A MacRae; Marwan M Refaat
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

Review 9.  Genetics and Epigenetics of Atrial Fibrillation.

Authors:  Estefanía Lozano-Velasco; Diego Franco; Amelia Aranega; Houria Daimi
Journal:  Int J Mol Sci       Date:  2020-08-10       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.